Cargando…
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders
BACKGROUND: Immune checkpoint blockade (ICB) response in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) is limited to 15%–20% of patients and underpinnings of resistance remain undefined. METHODS: Starting with an anti-PD1 sensitive murine HNSCC cell line, we generated an isogeni...
Autores principales: | Zhou, Liye, Zeng, Zexian, Egloff, Ann Marie, Zhang, Fan, Guo, Fei, Campbell, Katie M, Du, Peter, Fu, Jingxin, Zolkind, Paul, Ma, Xiaojing, Zhang, Zhe, Zhang, Yi, Wang, Xiaoqing, Gu, Shengqing, Riley, Rachel, Nakahori, Yasutaka, Keegan, Joshua, Haddad, Robert, Schoenfeld, Jonathan D, Griffith, Obi, Manguso, Robert T, Lederer, James A, Liu, X Shirley, Uppaluri, Ravindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772459/ https://www.ncbi.nlm.nih.gov/pubmed/35058328 http://dx.doi.org/10.1136/jitc-2021-004034 |
Ejemplares similares
-
TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response
por: Zeng, Zexian, et al.
Publicado: (2021) -
Integrating CD4(+) T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model
por: Shibata, Hirofumi, et al.
Publicado: (2021) -
Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma
por: Zolkind, Paul, et al.
Publicado: (2017) -
Personalized cancer vaccination in head and neck cancer
por: Shibata, Hirofumi, et al.
Publicado: (2021) -
Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer
por: Sui, Qiaoqi, et al.
Publicado: (2021)